Long-term effect of cilostazol on cerebral blood flow in chronic cerebral infarction. 1985

S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu

The effect of the oral administration of a new vasodilator, cilostazol (6-[4-(1-cyclohexyl-1H-tetrazol-5-yl) butoxy]-3,4-dihydro-2(1H)-quinolinone, OPC-13013) on cerebral circulation in chronic cerebral infarction was studied by the 133Xenon inhalation method. Mean regional cerebral blood flow (rCBF) was increased in 6 out of 14 cases after 2 weeks of treatment. Hemispheric rCBF was significantly increased in both the affected and non-affected sides (10.8 and 13.4%, respectively) (p less than 0.05) without causing a change in blood pressure.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002544 Cerebral Infarction The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction). Anterior Choroidal Artery Infarction,Cerebral Infarct,Infarction, Cerebral,Posterior Choroidal Artery Infarction,Subcortical Infarction,Cerebral Infarction, Left Hemisphere,Cerebral Infarction, Right Hemisphere,Cerebral, Left Hemisphere, Infarction,Cerebral, Right Hemisphere, Infarction,Infarction, Cerebral, Left Hemisphere,Infarction, Cerebral, Right Hemisphere,Infarction, Left Hemisphere, Cerebral,Infarction, Right Hemisphere, Cerebral,Left Hemisphere, Cerebral Infarction,Left Hemisphere, Infarction, Cerebral,Right Hemisphere, Cerebral Infarction,Right Hemisphere, Infarction, Cerebral,Cerebral Infarctions,Cerebral Infarcts,Infarct, Cerebral,Infarction, Subcortical,Infarctions, Cerebral,Infarctions, Subcortical,Infarcts, Cerebral,Subcortical Infarctions
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077407 Cilostazol A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke. 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone,OPC 13013,OPC-13013,Pletal
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
January 2001, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
September 1998, No to shinkei = Brain and nerve,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
February 2000, The Keio journal of medicine,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
October 1998, Internal medicine (Tokyo, Japan),
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
July 1986, Arzneimittel-Forschung,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
January 2018, Journal of the American Geriatrics Society,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
October 1999, Journal of cardiology,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
June 2009, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
December 1993, Clinical neuropharmacology,
S Kobayashi, and S Yamaguchi, and T Katsube, and M Kitani, and K Okada, and T Tsunematsu
September 1988, Klinicheskaia meditsina,
Copied contents to your clipboard!